Ferring Pharmaceuticals Chief Scientific Officer Dr. Elizabeth Garner guides clinical development, medical affairs, pharmacovigilance, project planning and regulatory affairs.
Garner has almost 30 years of experience in medicine and industry. Before joining Ferring in 2022, Garner held chief medical officer roles for biotech firm ObsEva and women’s healthcare company Agile Therapeutics. Earlier, she held leadership roles in medical affairs at Myriad Genetics Laboratories and clinical development at Abbott Laboratories and Merck Research Laboratories.
In the following interview, Garner shares what attracted her to drug discovery and development, how she addressed the toughest challenge of her career and the importance of mentorship.What first drew you to drug discovery and development? When did you first know you wanted to be in the industry?
Garner: As a woman who was born…